Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide

Author: Arndt C.A.S.   Nascimento A.G.   Schroeder G.   Schomberg P.J.   Neglia J.P.   Sencer S.F.   Silberman T.L.   Moertel C.L.   Tillisch J.K.   Miser J.S.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.34, Iss.8, 1998-07, pp. : 1224-1229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content